Black Diamond Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $499k | 132k | 3.79 |
| 2024-12-31 | $528k | 247k | 2.14 |
| 2024-09-30 | $1.2M | 284k | 4.35 |
| 2024-06-30 | $1.3M | 287k | 4.66 |
| 2024-03-31 | $1.6M | 315k | 5.07 |
| 2022-09-30 | $140k | 83k | 1.69 |
| 2022-06-30 | $30k | 12k | 2.43 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management